StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA)

Research analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDAGet Free Report) in a report issued on Saturday. The brokerage set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Stock Down 1.2 %

NASDAQ:RKDA opened at $5.01 on Friday. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The stock’s 50-day moving average price is $4.80 and its 200-day moving average price is $3.68. The stock has a market capitalization of $6.81 million, a PE ratio of -1.17 and a beta of 0.90.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.